73275-76-0 Usage
Uses
Used in Pharmaceutical Industry:
(Z)-7-[(1R)-3α,5α-Dihydroxy-2β-[(E,R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentan-1α-yl]-5-heptenoic acid methyl ester is used as a potential therapeutic agent for various medical applications due to its complex structure and the presence of functional groups that may interact with biological targets.
Used in Chemical Research:
In the field of chemical research, (Z)-7-[(1R)-3α,5α-Dihydroxy-2β-[(E,R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentan-1α-yl]-5-heptenoic acid methyl ester can be utilized as a starting material or a structural motif for the synthesis of novel molecules with potential applications in various industries, including pharmaceuticals, agrochemicals, and materials science.
Used in Drug Delivery Systems:
Similar to gallotannin, this complex organic compound may be employed in the development of innovative drug delivery systems to enhance its bioavailability, delivery, and therapeutic outcomes when targeting specific biological applications.
Check Digit Verification of cas no
The CAS Registry Mumber 73275-76-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,2,7 and 5 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 73275-76:
(7*7)+(6*3)+(5*2)+(4*7)+(3*5)+(2*7)+(1*6)=140
140 % 10 = 0
So 73275-76-0 is a valid CAS Registry Number.
InChI:InChI=1/C24H31F3O6/c1-32-23(31)10-5-3-2-4-9-19-20(22(30)14-21(19)29)12-11-17(28)15-33-18-8-6-7-16(13-18)24(25,26)27/h2,4,6-8,11-13,17,19-22,28-30H,3,5,9-10,14-15H2,1H3/b4-2-,12-11+/t17?,19?,20-,21?,22?/m1/s1
73275-76-0Relevant academic research and scientific papers
COMBINATION THERAPY
-
Paragraph 00234, (2014/09/29)
Described herein are compounds and compositions for treating glaucoma and/or reducing intraocular pressure. Compositions may comprise an isoquinoline compound and a prostaglandin or a prostaglandin analog. Compounds described herein include those in which an isoquinoline compound is covalently linked to a prostaglandin or a prostaglandin analog, and those in which an isoquinoline compound and a prostaglandin free acid together form a salt.
